MEDICAL DETECTION DOGS

1. MEDICAL DETECTION DOGS 2011-08-30 → present
2. CANCER AND BIO-DETECTION DOGS 2007-10-15 → 2011-08-30

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Saffery LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group or the parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. MEDICAL DETECTION DOGS · parent
   1. MDD Enterprises Limited 100% · England and Wales · Dormant
   2. Millfield Greenway Business Park Management Limited 75% · Property management
   3. Canine Diagnostic Innovations Limited 100% · England and Wales · Bio Detection Disease Research services

Significant events

• “re-launch our breeding programme during the past year, marking an important milestone in securing the future supply of dogs for our assistance and detection work. Shortly before Christmas, we welcomed a new litter of puppies”
• “new five-year strategy agreed with the Board of Trustees in March 2025”
• “made the difficult decision to pause our Colorectal Cancer study until additional funding is secured, and launched an urgent appeal at the start of 2025/26”
• “Our Bio Detection Research has seen encouraging progress, with notable advancements in our UTI detection pilot, including securing new partnerships with a local care home group, and provisional funding to accelerate this work.”
• “published two significant papers since the last annual report: Canine Bladder Cancer detection in December 2024 and our Parkinson's study in July 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

2

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -0.8%

  £2,080,224 → £2,064,349

• Cash

  -15.9%

  £2,119,558 → £1,781,511

• Net assets

  -12.8%

  £3,964,921 → £3,458,589

• Employees

  +13.6%

  44 → 50

• Wages

  +11.5%

  £1,395,852 → £1,557,022

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers